Which has higher valuation and earnings, SKYAW or DYNT?

SkyAI, Inc. Warrant has higher earnings, but lower revenue than Dynatronics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SkyAI, Inc. Warrant $396.90K 0.66 N/A N/A N/A Dynatronics $33.60M 0.00 -$2.70M -$1.35 N/A

Which has preferable earnings and valuation, SKYAW or BIOL?

SkyAI, Inc. Warrant has higher earnings, but lower revenue than BIOLASE. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SkyAI, Inc. Warrant $396.90K 0.66 N/A N/A N/A BIOLASE $48.83M 0.00 -$20.63M -$14.94 N/A

Do analysts recommend SKYAW or VERO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SkyAI, Inc. Warrant 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Venus Concept 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, SKYAW or VERO?

SkyAI, Inc. Warrant has higher earnings, but lower revenue than Venus Concept. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SkyAI, Inc. Warrant $396.90K 0.66 N/A N/A N/A Venus Concept $58.88M 0.01 -$47M -$48.84 N/A

Which has higher valuation and earnings, XAGE or SKYAW?

SkyAI, Inc. Warrant has lower revenue, but higher earnings than Longevity Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Longevity Health $1.05M 0.38 -$10.37M -$4.29 N/A SkyAI, Inc. Warrant $396.90K 0.66 N/A N/A N/A

Is XAGE or SKYAW more profitable?

SkyAI, Inc. Warrant has a net margin of 0.00% compared to Longevity Health's net margin of -682.67%. Company Net Margins Return on Equity Return on Assets Longevity Health -682.67% N/A -261.90% SkyAI, Inc. Warrant N/A N/A N/A

Do analysts prefer PFSA or SKYAW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profusa 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SkyAI, Inc. Warrant 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings and valuation, PFSA or SKYAW?

SkyAI, Inc. Warrant has higher revenue and earnings than Profusa. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Profusa $100K 2.01 -$35.82M -$4.24 thousand N/A SkyAI, Inc. Warrant $396.90K 0.66 N/A N/A N/A

Is PFSA or SKYAW more profitable?

Company Net Margins Return on Equity Return on Assets Profusa N/A N/A -1,348.07% SkyAI, Inc. Warrant N/A N/A N/A

SkyAI, Inc. Warrant (SKYAW) Competitors

$0.03 +0.01 (+20.56%)

As of 07/31/2026 12:16 PM Eastern

Compare

SKYAW vs. DYNT, BIOL, VERO, XAGE, and PFSA

Should you buy SkyAI, Inc. Warrant stock or one of its competitors? MarketBeat compares SkyAI, Inc. Warrant with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SkyAI, Inc. Warrant include Dynatronics (DYNT), BIOLASE (BIOL), Venus Concept (VERO), Longevity Health (XAGE), and Profusa (PFSA).

How does SkyAI, Inc. Warrant compare to Dynatronics?

SkyAI, Inc. Warrant (NASDAQ:SKYAW) and Dynatronics (NASDAQ:DYNT) are related small-cap companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

4.2% of Dynatronics shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

SkyAI, Inc. Warrant has higher earnings, but lower revenue than Dynatronics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SkyAI, Inc. Warrant	$396.90K	0.66	N/A	N/A	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

SkyAI, Inc. Warrant has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. SkyAI, Inc. Warrant's return on equity of 0.00% beat Dynatronics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SkyAI, Inc. Warrant	N/A	N/A	N/A
Dynatronics	-8.35%	-41.81%	-9.56%

In the previous week, SkyAI, Inc. Warrant's average media sentiment score of 1.89 beat Dynatronics' score of 0.00 indicating that SkyAI, Inc. Warrant is being referred to more favorably in the media.

Company	Overall Sentiment
SkyAI, Inc. Warrant	Very Positive
Dynatronics	Neutral

Summary

SkyAI, Inc. Warrant beats Dynatronics on 4 of the 7 factors compared between the two stocks.

How does SkyAI, Inc. Warrant compare to BIOLASE?

SkyAI, Inc. Warrant (NASDAQ:SKYAW) and BIOLASE (NASDAQ:BIOL) are related small-cap companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

8.8% of BIOLASE shares are held by institutional investors. 0.3% of BIOLASE shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

SkyAI, Inc. Warrant has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. SkyAI, Inc. Warrant's return on equity of 0.00% beat BIOLASE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SkyAI, Inc. Warrant	N/A	N/A	N/A
BIOLASE	-41.65%	-1,782.73%	-55.31%

In the previous week, SkyAI, Inc. Warrant's average media sentiment score of 1.89 beat BIOLASE's score of 0.00 indicating that SkyAI, Inc. Warrant is being referred to more favorably in the media.

Company	Overall Sentiment
SkyAI, Inc. Warrant	Very Positive
BIOLASE	Neutral

SkyAI, Inc. Warrant has higher earnings, but lower revenue than BIOLASE.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SkyAI, Inc. Warrant	$396.90K	0.66	N/A	N/A	N/A
BIOLASE	$48.83M	0.00	-$20.63M	-$14.94	N/A

Summary

SkyAI, Inc. Warrant beats BIOLASE on 4 of the 7 factors compared between the two stocks.

How does SkyAI, Inc. Warrant compare to Venus Concept?

SkyAI, Inc. Warrant (NASDAQ:SKYAW) and Venus Concept (NASDAQ:VERO) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.

SkyAI, Inc. Warrant has higher earnings, but lower revenue than Venus Concept.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SkyAI, Inc. Warrant	$396.90K	0.66	N/A	N/A	N/A
Venus Concept	$58.88M	0.01	-$47M	-$48.84	N/A

In the previous week, Venus Concept had 1 more articles in the media than SkyAI, Inc. Warrant. MarketBeat recorded 1 mentions for Venus Concept and 0 mentions for SkyAI, Inc. Warrant. SkyAI, Inc. Warrant's average media sentiment score of 1.89 beat Venus Concept's score of 0.00 indicating that SkyAI, Inc. Warrant is being referred to more favorably in the media.

Company	Overall Sentiment
SkyAI, Inc. Warrant	Very Positive
Venus Concept	Neutral

SkyAI, Inc. Warrant has a net margin of 0.00% compared to Venus Concept's net margin of -92.76%. SkyAI, Inc. Warrant's return on equity of 0.00% beat Venus Concept's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SkyAI, Inc. Warrant	N/A	N/A	N/A
Venus Concept	-92.76%	-1,904.25%	-85.22%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SkyAI, Inc. Warrant	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Venus Concept	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

87.4% of Venus Concept shares are owned by institutional investors. 28.0% of Venus Concept shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

SkyAI, Inc. Warrant and Venus Concept tied by winning 5 of the 10 factors compared between the two stocks.

How does SkyAI, Inc. Warrant compare to Longevity Health?

Longevity Health (NASDAQ:XAGE) and SkyAI, Inc. Warrant (NASDAQ:SKYAW) are related small-cap companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk and dividends.

24.2% of Longevity Health shares are owned by institutional investors. 29.0% of Longevity Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, SkyAI, Inc. Warrant's average media sentiment score of 1.89 beat Longevity Health's score of 0.00 indicating that SkyAI, Inc. Warrant is being referred to more favorably in the news media.

Company	Overall Sentiment
Longevity Health	Neutral
SkyAI, Inc. Warrant	Very Positive

SkyAI, Inc. Warrant has a net margin of 0.00% compared to Longevity Health's net margin of -682.67%.

Company	Net Margins	Return on Equity	Return on Assets
Longevity Health	-682.67%	N/A	-261.90%
SkyAI, Inc. Warrant	N/A	N/A	N/A

SkyAI, Inc. Warrant has lower revenue, but higher earnings than Longevity Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Longevity Health	$1.05M	0.38	-$10.37M	-$4.29	N/A
SkyAI, Inc. Warrant	$396.90K	0.66	N/A	N/A	N/A

Summary

SkyAI, Inc. Warrant beats Longevity Health on 4 of the 7 factors compared between the two stocks.

How does SkyAI, Inc. Warrant compare to Profusa?

Profusa (NASDAQ:PFSA) and SkyAI, Inc. Warrant (NASDAQ:SKYAW) are related small-cap companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

In the previous week, Profusa had 7 more articles in the media than SkyAI, Inc. Warrant. MarketBeat recorded 7 mentions for Profusa and 0 mentions for SkyAI, Inc. Warrant. SkyAI, Inc. Warrant's average media sentiment score of 1.89 beat Profusa's score of 0.56 indicating that SkyAI, Inc. Warrant is being referred to more favorably in the news media.

Company	Overall Sentiment
Profusa	Positive
SkyAI, Inc. Warrant	Very Positive

SkyAI, Inc. Warrant has higher revenue and earnings than Profusa.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profusa	$100K	2.01	-$35.82M	-$4.24 thousand	N/A
SkyAI, Inc. Warrant	$396.90K	0.66	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profusa	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SkyAI, Inc. Warrant	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

9.8% of Profusa shares are held by institutional investors. 0.8% of Profusa shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
Profusa	N/A	N/A	-1,348.07%
SkyAI, Inc. Warrant	N/A	N/A	N/A

Summary

Profusa beats SkyAI, Inc. Warrant on 5 of the 8 factors compared between the two stocks.

Get SkyAI, Inc. Warrant News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SKYAW vs. The Competition

Export

Metric	SkyAI, Inc. Warrant	Financial Services Industry	Finance Sector	NASDAQ Exchange
Market Cap	$263K	$27.10B	$13.64B	$12.30B
Dividend Yield	N/A	5.77%	5.96%	9.45%
P/E Ratio	N/A	19.41	28.67	24.66
Price / Sales	0.66	386.37	460.81	110.52
Price / Cash	N/A	157.07	53.11	59.62
Price / Book	N/A	3.29	3.68	5.90
Net Income	N/A	$1.09B	$1.31B	$336.31M
7 Day Performance	N/A	0.08%	4.00%	0.09%
1 Month Performance	N/A	-3.29%	-0.13%	-5.67%
1 Year Performance	N/A	-10.09%	13.23%	18.79%

SkyAI, Inc. Warrant Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SKYAW SkyAI, Inc. Warrant	N/A	$0.03 +20.6%	N/A	+20.1%	$263K	$396.90K	N/A	3	Positive News Gap Down
DYNT Dynatronics	N/A	N/A	N/A	N/A	$653K	$33.60M	N/A	200
BIOL BIOLASE	N/A	N/A	N/A	N/A	$581K	$48.83M	N/A	160
VERO Venus Concept	0.0606 of 5 stars	$0.31 flat	N/A	N/A	$442K	$58.88M	N/A	410
XAGE Longevity Health	N/A	$0.21 -12.1%	N/A	-92.3%	$376K	$1.05M	N/A	14	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SKYAW) was last updated on 8/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SkyAI, Inc. Warrant (SKYAW) Competitors

SKYAW vs. DYNT, BIOL, VERO, XAGE, and PFSA

How does SkyAI, Inc. Warrant compare to Dynatronics?

Summary

How does SkyAI, Inc. Warrant compare to BIOLASE?

Summary

How does SkyAI, Inc. Warrant compare to Venus Concept?

Summary

How does SkyAI, Inc. Warrant compare to Longevity Health?

Summary

How does SkyAI, Inc. Warrant compare to Profusa?

Summary

Media Sentiment Over Time

SKYAW vs. The Competition

SkyAI, Inc. Warrant Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SkyAI, Inc. Warrant (SKYAW) Competitors

SKYAW vs. DYNT, BIOL, VERO, XAGE, and PFSA

How does SkyAI, Inc. Warrant compare to Dynatronics?

Do institutionals & insiders have more ownership in SKYAW or DYNT?

Which has higher valuation and earnings, SKYAW or DYNT?

Is SKYAW or DYNT more profitable?

Does the media favor SKYAW or DYNT?

Summary

How does SkyAI, Inc. Warrant compare to BIOLASE?

Do institutionals & insiders believe in SKYAW or BIOL?

Is SKYAW or BIOL more profitable?

Does the media prefer SKYAW or BIOL?

Which has preferable earnings and valuation, SKYAW or BIOL?

Summary

How does SkyAI, Inc. Warrant compare to Venus Concept?

Which has preferable earnings & valuation, SKYAW or VERO?

Does the media refer more to SKYAW or VERO?

Is SKYAW or VERO more profitable?

Do analysts recommend SKYAW or VERO?

Do institutionals & insiders hold more shares of SKYAW or VERO?

Summary

How does SkyAI, Inc. Warrant compare to Longevity Health?

Do insiders & institutionals have more ownership in XAGE or SKYAW?

Does the media refer more to XAGE or SKYAW?

Is XAGE or SKYAW more profitable?

Which has higher valuation and earnings, XAGE or SKYAW?

Summary

How does SkyAI, Inc. Warrant compare to Profusa?

Does the media prefer PFSA or SKYAW?

Which has better earnings and valuation, PFSA or SKYAW?

Do analysts prefer PFSA or SKYAW?

Do insiders and institutionals hold more shares of PFSA or SKYAW?

Is PFSA or SKYAW more profitable?

Summary

Media Sentiment Over Time

SKYAW vs. The Competition

SkyAI, Inc. Warrant Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools